Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: DexCom, Inc.

Market Cap 2.91TCr 2.51TCr 2.31TCr 2.17TCr 4.06TCr 2,76400Cr 4.12TCr 27TCr 11TCr 1,34600Cr 11TCr 11TCr 4,65900Cr P/E Ratio 2026 *
30.8x
P/E Ratio 2027 * 25.8x
Enterprise Value 2.87TCr 2.48TCr 2.29TCr 2.14TCr 4.01TCr 2,72900Cr 4.07TCr 27TCr 11TCr 1,32800Cr 11TCr 11TCr 4,60000Cr EV / Sales 2026 *
5.5x
EV / Sales 2027 * 4.77x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 day+0.16%
1 week+3.44%
Current month+2.21%
1 month+28.68%
3 months+17.33%
6 months+12.56%
Current year+13.56%
1 week 73
Extreme 73
78.91
1 month 59.46
Extreme 59.46
78.91
Current year 56.72
Extreme 56.72
78.91
1 year 54.11
Extreme 54.11
89.98
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Date Insider Type Main position Quantity % Market Cap.
04/06Sell

Executive/Senior Manager

-4,911 0.0013%
28/05Free

Director

5,605 0.0015%
28/05Free

Director

5,605 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+0.16%+3.44%-8.07%-40.16% 2.91TCr
-1.64%-3.17%-34.98%-13.43% 15TCr
-0.16%-1.80%-8.10%-6.47% 10TCr
+3.00%+0.30%+58.58%+48.55% 5.52TCr
+0.07%+2.41%-4.69%+56.67% 5.48TCr
-0.75%-3.25%-15.08%-41.85% 4.03TCr
-1.40%+8.93% - - 3.1TCr
-0.46%+4.55%+48.18%-8.10% 2.32TCr
-2.85%-3.53%-15.70%-1.83% 2.03TCr
+0.16%-2.26%-14.00%-0.01% 2.02TCr
Average -0.39%+0.69%+0.68%-0.74% 5.31TCr
Weighted average by Cap. -0.44%-0.39%-7.11%-0.05%

Financials

2026 *2027 *
Net sales 522.48Cr 451.26Cr 415.84Cr 389.25Cr 729.47Cr 50TCr 740.77Cr 4.91TCr 1.91TCr 24TCr 1.96TCr 1.92TCr 84TCr 582.98Cr 503.52Cr 463.99Cr 434.32Cr 813.94Cr 55TCr 826.55Cr 5.48TCr 2.14TCr 27TCr 2.19TCr 2.14TCr 93TCr
Net income 96Cr 83Cr 77Cr 72Cr 134.39Cr 9.15TCr 136.47Cr 904.6Cr 352.69Cr 4.45TCr 361.25Cr 353.56Cr 15TCr 115.77Cr 100Cr 92Cr 86Cr 161.64Cr 11TCr 164.14Cr 1.09TCr 424.2Cr 5.36TCr 434.49Cr 425.24Cr 19TCr
Net Debt -37Cr -32Cr -29Cr -28Cr -52Cr -3.51TCr -52Cr -347.26Cr -135.39Cr -1.71TCr -138.68Cr -135.72Cr -5.92TCr -124.76Cr -107.75Cr -99Cr -93Cr -174.18Cr -12TCr -176.88Cr -1.17TCr -457.12Cr -5.77TCr -468.21Cr -458.24Cr -20TCr
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
12/26/12 75.37 $ +0.16% 47,73,926
11/26/11 75.25 $ +0.64% 66,07,417
10/26/10 74.77 $ -4.37% 50,38,093
09/26/09 78.19 $ +2.05% 54,24,011
08/26/08 76.62 $ +5.16% 75,71,679
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
75.37USD
Average target price
84.67USD
Spread / Average Target
+12.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!